Seach Medical Group is leading the Israeli export with a first of its kind commercial export to Cannatrek, based in Australia.

Seach's CEO, Mr. Yogev Sarid: "Today will be remembered as an historical day for the Israeli medical cannabis industry, and we are confident that this shipment is a solid starting point for years to come". In the first shipment the company will export one of its most popular strains in the Israeli market, Black Label.

Givat Chen, November 16, 2020, Seach Medical Group (TASE: SEMG.TA), one of the pioneering companies in the Israeli and global medical cannabis industry, reports that it has successfully received the final approval from the Israeli MOH and custom authorities for the first commercial export of the company’s medical cannabis inflorescence, that were manufactured by Seach’s EU-GMP manufacturing partner, Panaxia pharmaceuticals Ltd. The products destination is Australia, to Seach’s partner Cannatrek Medical Pty Ltd. In addition to this export, Seach estimates that is shall receive in the near future additional export permits to additional countries worldwide.

Seach will be exporting final products of one of its most popular strains in the Israeli market, the Black Label, which is an Indica dominant flower. In the future, Seach will export additional strains, which are based on more than 13 years of experience  and expertise in the medical cannabis industry, and are characterized with large repeatability and genetic uniqueness. All the products were manufactured as part of Seach’s strategic collaboration with Panaxia Pharmaceuticals Ltd., which is EU-GMP compliant.

Seach Medical Group CEO, Mr. Yogev Sarid: “We are proud and happy to make history and be the first to report commercial exports of medical cannabis from Israel. Today is a historical day for the Israeli cannabis industry and we believe that this shipment is a solid starting point for years to come. After years of anticipation for export and more than a decade of experience in the medical cannabis industry, we at Seach are very excited to export the first commercial shipment from Israel to our friends at Cannatrek, Australia. I am confident that Seach will continue to lead the Israeli market while creating interesting partnerships and opportunities worldwide as we have done so far”.

Cannatrek Limited CEO, Mr Tommy Huppert: “After watching the Israel medicinal cannabis industry lead the world for over 10 years and to introduce new novel medicines that have shown to assist a variety of indications, we are extremely excited to partner with Seach Medical Group. Australia is one of the fastest growing market in the world today and we look forward to collaborating on medical and agronomic research to support patient access and offer an alternative therapeutic product to our growing patient base in Australia”.